Odonate Therapeutics Inc (ODT)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -204.237 | -31.733 | -51.397 | -67.466 | -70.841 | -55.342 | 46.999 | 6.84 |
Return on Equity (%) | -257.728 | -33.031 | -55.602 | -78.116 | -84.672 | -69.92 | 53.637 | 7.011 |
Return on Invested Capital (%) | -257.728 | -33.094 | -56.972 | -81.029 | -86.372 | -70.948 | 56.225 | -5.812 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.45 | 7.288 | 4.636 | 5.064 | 3.531 | 1.954 | 3.448 | 7.392 |
Earnings Per Share | -0.608 | -1.218 | -3.326 | -3.489 | -3.277 | -2.252 | 1.468 | 0.501 |
Cash Per Share | 0.512 | 7.367 | 5.199 | 5.63 | 4.078 | 2.271 | 0.367 | 2.704 |
Working Capital Per Share | 0.447 | 7.268 | 4.546 | 4.965 | 3.444 | 1.956 | 1.63 | 3.868 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.608 | -1.218 | -3.326 | -3.489 | -3.277 | -2.252 | 0.329 | 0.646 |
EBITDA Per Share | -0.608 | -1.218 | -3.326 | -3.489 | -3.277 | -2.252 | 0.329 | 0.646 |
Free Cash Flow Per Share | -0.452 | -1.215 | -3.268 | -3.496 | -3.277 | -2.267 | 1.464 | 0.499 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 5.07M | 26.89M | 26.75M | 32.05M | 38.56M | 30.33M | 29.25M | 14.63M |
Year End December 30 2023 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Dec 2022 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 32.11M | 38.53M | 38.56M | 38.06M | 38.5M | 38.49M | 30.33M | 29.25M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 16.38M |
Price to Earnings Ratio | 2.24 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.41 |
Price to Book Ratio | 0.15 |
Dividend Yield | - |
Shares Outstanding | 14.63M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.